drugset / Trial / NCT03066622
Olanzapine for Acute Headaches
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is a prospective, randomized, feasibility trial with the primary aim of comparing how well oral rapidly dissolving olanzapine controls primary headache pain when compared to the current treatment strategies used in emergency departments which often require intravenous or intramuscular medications.
Timeline
- Start
- 2016-07
- Primary completion
- 2018-05-17
- Completion
- 2018-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 5 mg | Oral |